Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.

HLA-DRB1 shared epitope (SE) alleles are the strongest genetic determinants for autoantibody positive rheumatoid arthritis (RA). One of the key regulators in expression of HLA class II receptors is MHC class II transactivator (CIITA). A variant of the CIITA gene has been found to associate with infl...

Full description

Bibliographic Details
Main Authors: Marcus Ronninger, Maria Seddighzadeh, Morten Christoph Eike, Darren Plant, Nina A Daha, Beate Skinningsrud, Jane Worthington, Tore K Kvien, Rene E M Toes, Benedicte A Lie, Lars Alfredsson, Leonid Padyukov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3312880?pdf=render
id doaj-8a36cd766198420392d7d345949bfe68
record_format Article
spelling doaj-8a36cd766198420392d7d345949bfe682020-11-25T00:47:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3286110.1371/journal.pone.0032861Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.Marcus RonningerMaria SeddighzadehMorten Christoph EikeDarren PlantNina A DahaBeate SkinningsrudJane WorthingtonTore K KvienRene E M ToesBenedicte A LieLars AlfredssonLeonid PadyukovHLA-DRB1 shared epitope (SE) alleles are the strongest genetic determinants for autoantibody positive rheumatoid arthritis (RA). One of the key regulators in expression of HLA class II receptors is MHC class II transactivator (CIITA). A variant of the CIITA gene has been found to associate with inflammatory diseases.We wanted to explore whether the risk variant rs3087456 in the CIITA gene interacts with the HLA-DRB1 SE alleles regarding the risk of developing RA. We tested this hypothesis in a case-control study with 11767 individuals from four European Caucasian populations (6649 RA cases and 5118 controls).We found no significant additive interaction for risk alleles among Swedish Caucasians with RA (n = 3869, attributable proportion due to interaction (AP) = 0.2, 95%CI: -0.2-0.5) or when stratifying for anti-citrullinated protein antibodies (ACPA) presence (ACPA positive disease: n = 2945, AP = 0.3, 95%CI: -0.05-0.6, ACPA negative: n = 2268, AP = -0.2, 95%CI: -1.0-0.6). We further found no significant interaction between the main subgroups of SE alleles (DRB1*01, DRB1*04 or DRB1*10) and CIITA. Similar analysis of three independent RA cohorts from British, Dutch and Norwegian populations also indicated an absence of significant interaction between genetic variants in CIITA and SE alleles with regard to RA risk.Our data suggest that risk from the CIITA locus is independent of the major risk for RA from HLA-DRB1 SE alleles, given that no significant interaction between rs3087456 and SE alleles was observed. Since a biological link between products of these genes is evident, the genetic contribution from CIITA and class II antigens in the autoimmune process may involve additional unidentified factors.http://europepmc.org/articles/PMC3312880?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Marcus Ronninger
Maria Seddighzadeh
Morten Christoph Eike
Darren Plant
Nina A Daha
Beate Skinningsrud
Jane Worthington
Tore K Kvien
Rene E M Toes
Benedicte A Lie
Lars Alfredsson
Leonid Padyukov
spellingShingle Marcus Ronninger
Maria Seddighzadeh
Morten Christoph Eike
Darren Plant
Nina A Daha
Beate Skinningsrud
Jane Worthington
Tore K Kvien
Rene E M Toes
Benedicte A Lie
Lars Alfredsson
Leonid Padyukov
Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
PLoS ONE
author_facet Marcus Ronninger
Maria Seddighzadeh
Morten Christoph Eike
Darren Plant
Nina A Daha
Beate Skinningsrud
Jane Worthington
Tore K Kvien
Rene E M Toes
Benedicte A Lie
Lars Alfredsson
Leonid Padyukov
author_sort Marcus Ronninger
title Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
title_short Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
title_full Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
title_fullStr Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
title_full_unstemmed Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
title_sort interaction analysis between hla-drb1 shared epitope alleles and mhc class ii transactivator ciita gene with regard to risk of rheumatoid arthritis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description HLA-DRB1 shared epitope (SE) alleles are the strongest genetic determinants for autoantibody positive rheumatoid arthritis (RA). One of the key regulators in expression of HLA class II receptors is MHC class II transactivator (CIITA). A variant of the CIITA gene has been found to associate with inflammatory diseases.We wanted to explore whether the risk variant rs3087456 in the CIITA gene interacts with the HLA-DRB1 SE alleles regarding the risk of developing RA. We tested this hypothesis in a case-control study with 11767 individuals from four European Caucasian populations (6649 RA cases and 5118 controls).We found no significant additive interaction for risk alleles among Swedish Caucasians with RA (n = 3869, attributable proportion due to interaction (AP) = 0.2, 95%CI: -0.2-0.5) or when stratifying for anti-citrullinated protein antibodies (ACPA) presence (ACPA positive disease: n = 2945, AP = 0.3, 95%CI: -0.05-0.6, ACPA negative: n = 2268, AP = -0.2, 95%CI: -1.0-0.6). We further found no significant interaction between the main subgroups of SE alleles (DRB1*01, DRB1*04 or DRB1*10) and CIITA. Similar analysis of three independent RA cohorts from British, Dutch and Norwegian populations also indicated an absence of significant interaction between genetic variants in CIITA and SE alleles with regard to RA risk.Our data suggest that risk from the CIITA locus is independent of the major risk for RA from HLA-DRB1 SE alleles, given that no significant interaction between rs3087456 and SE alleles was observed. Since a biological link between products of these genes is evident, the genetic contribution from CIITA and class II antigens in the autoimmune process may involve additional unidentified factors.
url http://europepmc.org/articles/PMC3312880?pdf=render
work_keys_str_mv AT marcusronninger interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT mariaseddighzadeh interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT mortenchristopheike interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT darrenplant interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT ninaadaha interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT beateskinningsrud interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT janeworthington interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT torekkvien interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT reneemtoes interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT benedictealie interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT larsalfredsson interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
AT leonidpadyukov interactionanalysisbetweenhladrb1sharedepitopeallelesandmhcclassiitransactivatorciitagenewithregardtoriskofrheumatoidarthritis
_version_ 1725262054702448640